Top USFDA Officials Tour Divi's Labs Production Facilities in Hyderabad

In a notable development, a high-ranking delegation from the US Food & Drug Administration (FDA), led by Commissioner Dr. Robert M. Califf, paid a visit to the manufacturing facilities of Divi's Laboratories, an active pharmaceutical ingredients (API) manufacturer based in Hyderabad. During the visit, Divi's Laboratories showcased its extensive, state-of-the-art production facilities, advanced automated manufacturing capabilities, commitment to innovation, and its significant investment in new technologies aimed at ensuring a consistent supply of high-quality APIs.

The USFDA delegation engaged in discussions with Divi's Laboratories' top management, noting that the company supplies APIs to more than 100 countries. The visit covered a broad spectrum of topics, reflecting the ever-evolving landscape of the API industry. Discussions included the integration of new technologies, sustainable practices in chemistry, elevating manufacturing standards, and ensuring the availability of APIs.

Dr. Kiran S. Divi, CEO of Divi's Laboratories Limited, expressed pride in participating in this significant visit, emphasizing the company's role as a dependable API manufacturer capable of delivering large quantities within a relatively short timeframe. He also expressed enthusiasm for continued engagement and collaboration in addressing critical issues affecting the global pharmaceutical industry.